Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis
IntroductionCalcific aortic valve disease (CAVD) is increasingly prevalent among the aging population, and there is a notable lack of drug therapies. Consequently, identifying novel drug targets will be of utmost importance. Given that type 2 diabetes is an important risk factor for CAVD, we identif...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1506663/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846116328659746816 |
|---|---|
| author | Qiang Shen Lin Fan Chen Jiang Dingyi Yao Xingyu Qian Fuqiang Tong Zhengfeng Fan Zongtao Liu Nianguo Dong Chao Zhang Jiawei Shi |
| author_facet | Qiang Shen Lin Fan Chen Jiang Dingyi Yao Xingyu Qian Fuqiang Tong Zhengfeng Fan Zongtao Liu Nianguo Dong Chao Zhang Jiawei Shi |
| author_sort | Qiang Shen |
| collection | DOAJ |
| description | IntroductionCalcific aortic valve disease (CAVD) is increasingly prevalent among the aging population, and there is a notable lack of drug therapies. Consequently, identifying novel drug targets will be of utmost importance. Given that type 2 diabetes is an important risk factor for CAVD, we identified key genes associated with diabetes - related CAVD via various bioinformatics methods, which provide further potential molecular targets for CAVD with diabetes.MethodsThree transcriptome datasets related to CAVD and two related to diabetes were retrieved from the Gene Expression Omnibus (GEO) database. To distinguish key genes, differential expression analysis with the “Limma” package and WGCNA was applied. Machine learning (ML) algorithms were employed to screen potential biomarkers. The receiver operating characteristic curve (ROC) and nomogram were then constructed. The CIBERSORT algorithm was utilized to investigate immune cell infiltration in CAVD. Lastly, the association between the hub genes and 22 types of infiltrating immune cells was evaluated.ResultsBy intersecting the results of the “Limma” and WGCNA analyses, 727 and 190 CAVD - related genes identified from the GSE76717 and GSE153555 datasets were obtained. Then, through differential analysis and interaction, 619 genes shared by the two diabetes mellitus datasets were acquired. Next, we intersected the differential genes and module genes of CAVD with the differential genes of diabetes, and the obtained genes were used for subsequent analysis. ML algorithms and the PPI network yielded a total of 12 genes, 10 of which showed a higher diagnostic value. Immune cell infiltration analysis revealed that immune dysregulation was closely linked to CAVD progression. Experimentally, we have verified the gene expression differences of MFAP5, which has the potential to serve as a diagnostic biomarker for CAVD.ConclusionIn this study, a multi-omics approach was used to identify 10 CAVD-related biomarkers (COL5A1, COL5A2, THBS2, MFAP5, BTG2, COL1A1, COL1A2, MXRA5, LUM, CD34) and to develop an exploratory risk model. Western blot (WB) and immunofluorescence experiments revealed that MFAP5 plays a crucial role in the progression of CAVD in the context of diabetes, offering new insights into the disease mechanism. |
| format | Article |
| id | doaj-art-7de2e1d4f1814cb4808170e5efd3bd5c |
| institution | Kabale University |
| issn | 1664-3224 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-7de2e1d4f1814cb4808170e5efd3bd5c2024-12-19T05:10:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-12-011510.3389/fimmu.2024.15066631506663Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysisQiang ShenLin FanChen JiangDingyi YaoXingyu QianFuqiang TongZhengfeng FanZongtao LiuNianguo DongChao ZhangJiawei ShiIntroductionCalcific aortic valve disease (CAVD) is increasingly prevalent among the aging population, and there is a notable lack of drug therapies. Consequently, identifying novel drug targets will be of utmost importance. Given that type 2 diabetes is an important risk factor for CAVD, we identified key genes associated with diabetes - related CAVD via various bioinformatics methods, which provide further potential molecular targets for CAVD with diabetes.MethodsThree transcriptome datasets related to CAVD and two related to diabetes were retrieved from the Gene Expression Omnibus (GEO) database. To distinguish key genes, differential expression analysis with the “Limma” package and WGCNA was applied. Machine learning (ML) algorithms were employed to screen potential biomarkers. The receiver operating characteristic curve (ROC) and nomogram were then constructed. The CIBERSORT algorithm was utilized to investigate immune cell infiltration in CAVD. Lastly, the association between the hub genes and 22 types of infiltrating immune cells was evaluated.ResultsBy intersecting the results of the “Limma” and WGCNA analyses, 727 and 190 CAVD - related genes identified from the GSE76717 and GSE153555 datasets were obtained. Then, through differential analysis and interaction, 619 genes shared by the two diabetes mellitus datasets were acquired. Next, we intersected the differential genes and module genes of CAVD with the differential genes of diabetes, and the obtained genes were used for subsequent analysis. ML algorithms and the PPI network yielded a total of 12 genes, 10 of which showed a higher diagnostic value. Immune cell infiltration analysis revealed that immune dysregulation was closely linked to CAVD progression. Experimentally, we have verified the gene expression differences of MFAP5, which has the potential to serve as a diagnostic biomarker for CAVD.ConclusionIn this study, a multi-omics approach was used to identify 10 CAVD-related biomarkers (COL5A1, COL5A2, THBS2, MFAP5, BTG2, COL1A1, COL1A2, MXRA5, LUM, CD34) and to develop an exploratory risk model. Western blot (WB) and immunofluorescence experiments revealed that MFAP5 plays a crucial role in the progression of CAVD in the context of diabetes, offering new insights into the disease mechanism.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1506663/fullCAVDdiabetesWGCNAmachine learningimmune infiltration |
| spellingShingle | Qiang Shen Lin Fan Chen Jiang Dingyi Yao Xingyu Qian Fuqiang Tong Zhengfeng Fan Zongtao Liu Nianguo Dong Chao Zhang Jiawei Shi Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis Frontiers in Immunology CAVD diabetes WGCNA machine learning immune infiltration |
| title | Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis |
| title_full | Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis |
| title_fullStr | Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis |
| title_full_unstemmed | Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis |
| title_short | Identification and validation of the diagnostic biomarker MFAP5 for CAVD with type 2 diabetes by bioinformatics analysis |
| title_sort | identification and validation of the diagnostic biomarker mfap5 for cavd with type 2 diabetes by bioinformatics analysis |
| topic | CAVD diabetes WGCNA machine learning immune infiltration |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1506663/full |
| work_keys_str_mv | AT qiangshen identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT linfan identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT chenjiang identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT dingyiyao identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT xingyuqian identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT fuqiangtong identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT zhengfengfan identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT zongtaoliu identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT nianguodong identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT chaozhang identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis AT jiaweishi identificationandvalidationofthediagnosticbiomarkermfap5forcavdwithtype2diabetesbybioinformaticsanalysis |